as on September 18, 2025 at 1:29 am IST
Day's Low
Day's High
0.70%
Downside
5.63%
Upside
52 Week's Low
52 Week's High
28.87%
Downside
214.08%
Upside
Check Zentalis Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$102.4M
EPS (TTM)
-1.9571
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0P/B Ratio
0PEG Ratio
0EBITDA
-170.4M
Revenue (TTM)
26.9M
Profit Margin
0.00%
Return On Equity TTM
129007800.00%
Compare market cap, revenue, PE, and other key metrics of Zentalis Pharmaceuticals Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $102.4M | -95.49% | NA | 0.00% | |
BUY | $60.5B | 252.04% | -505.15 | -12.96% | |
NA | $39.0B | NA | NA | -3.89% | |
BUY | $100.3B | 44.17% | 27.85 | 31.86% | |
BUY | $59.6B | 1.78% | 14.1 | 31.37% |
The Zentalis Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Zentalis Pharmaceuticals Inc investment value today
Current value as on today
₹39,232
Returns
Returns from Zentalis Pharmaceuticals Inc Stock
Dollar Returns*
₹4,598 (+4.6%)
Based on 17 analysts
82.35%
Buy
17.65%
Hold
0.00%
Sell
Based on 17 analysts, 82.35% of analysts recommend a 'BUY' rating for Zentalis Pharmaceuticals Inc. Average target price of $6.19
Get share price movements and forecasts by analysts on Zentalis Pharmaceuticals Inc.
What analysts predicted
77.06%UPSIDE
Target Price
$6.19
Current Price
$1.42
Analyzed by
17 Analysts
Target
$6.19
Zentalis Pharmaceuticals Inc target price $6.19, a slight upside of 77.06% compared to current price of $1.42. According to 17 analysts rating.
Search interest for Zentalis Pharmaceuticals Inc Stock has decreased by -17% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.9% return, outperforming this stock by 134.8%
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 210.5%
Price Dip
In the last 7 days, ZNTL stock has moved down by -9.0%
Organisation | Zentalis Pharmaceuticals Inc |
Headquarters | 10275 Science Center Dr., San Diego, CA, United States, 92121 |
Industry | Health Technology |
CEO | Ms. Julie M. Eastland M.B.A. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Rajesh Israni | Senior VP of Regulatory Affairs & Medical Writing |
Mr. Henry Gu | Senior VP & Head of Intellectual Property |
Ms. Julie M. Eastland M.B.A. | CEO, President & Director |
Mr. Robert J. DiVasto P.E. | Senior Vice President of Technical Operations |
Dr. Ingmar Bruns M.D., Ph.D. | Chief Medical Officer |
Mr. Haibo Wang | Chief Business Officer |
Ms. Andrea Paul J.D. | Chief Legal Officer & Corporate Secretary |
Mr. Vincent A. Vultaggio | SVP of Finance & Principal Accounting Officer |
Ms. Wendy Chang | Chief People Officer |
Zentalis Pharmaceuticals Inc share price today is $1.42 as on at the close of the market. Zentalis Pharmaceuticals Inc share today touched a day high of $1.5 and a low of $1.41.
Zentalis Pharmaceuticals Inc share touched a 52 week high of $4.46 on and a 52 week low of $1.01 on . Zentalis Pharmaceuticals Inc stock price today i.e. is closed at $1.42,which is 68.16% down from its 52 week high and 40.59% up from its 52 week low.
Zentalis Pharmaceuticals Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Zentalis Pharmaceuticals Inc (ZNTL) shares with as little as ₹87.816 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Zentalis Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Zentalis Pharmaceuticals Inc share’s latest price of $1.42 as on September 18, 2025 at 1:29 am IST, you will get 7.0423 shares of Zentalis Pharmaceuticals Inc. Learn more about
fractional shares .
Zentalis Pharmaceuticals Inc stock has given -95.49% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?